4 studies found for: (lymphoma [CONDITION] OR CLL [CONDITION]) AND immunocytokine [TREATMENT]
Open-Label Extension Study of De-immunized DI-Leu16-IL2 Immunocytokine Administered in Patients With B-cell NHL
Phase I/II Study of De-immunized DI-Leu16-IL2 Immunocytokine Administered Subcutaneously in Patients With B-cell NHL
Fusion Protein Cytokine Therapy After Rituximab in Treating Patients With B-Cell Non-Hodgkin Lymphoma
EMD 521873 in Advanced Solid Tumors, MTD Finding
† Study has passed its completion date and status has not been verified in more than two years.